Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
investment
Pharma
Novartis pledges nearly $480M to bolster China production, R&D
Amid a spate of pharma investments in China, Novartis is the latest drugmaker lining up to bolster its R&D and production operations in the country.
Fraiser Kansteiner
Mar 23, 2026 10:35am
Lilly telegraphs $126M Japan production expansion
Mar 12, 2026 11:41am
CSL firms up details on $1.5B US plasma-based medicines plant
Mar 10, 2026 10:30am
J&J drafts designs for $1B cell therapy plant in Pennsylvania
Feb 18, 2026 11:23am
Lilly drafts plan for last of 4 new US drug manufacturing plants
Jan 30, 2026 11:00am
Fierce Biotech
New rules, higher stakes: Biopharma plays the long game in 2026
Jan 26, 2026 2:40pm
